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Murine Thy-1 +. TCR Vy3NBt + dendritic epidennal 
T cells (DETC) express CD2 antigens. but differ from 
most other T-cell subsets in their absence of CD4. 
CDS. and CDS antigens. To determine whether neg­
ativity for those antigens is an intrinsic feature of a 
given T-cell population or whether such triple-neg­
ative T cells go through a maturational stage during 
which they express these antigens. we determined the 
phenotype ofTCR Vy3+ fetal thymocytes. which are 
the precursor cells of DETC. We found that TCR 
Vy3 + fetal thymocytes at day 17 of gestation are 
CD2+. CDS+. mosdy CDS+. and pardy CD4+. The 
expression of CDS is highest on early TCR Vy3+ 
thymocytes; these cells express intermediate levels of 
CDS when they leave the thymus and lose CDS 
CHARACTERIZATION AND ONTOGENY OF DENDRITIC 
EPIDERMAL T CELLS (DETC) 
The murine epidermis contains two populations of bone-marrow­
derived dendritic cells, major histocompatibility complex (MHC) 
class 11+ Langerhans cells and Thy-1 + dendritic epidermal T cells 
(DETC or Thy-1 + DEC). The presence of dendritic Thy-l + cells in 
the epidermis was first reported in 19S3. Besides Thy-1, these cells 
express CD4S and asialo-GM1 antigens, but they are negative for 
CDS, CD4, CDS, and MHC class II antigens [1,2]. Because of this 
phenotype , it was not clear whether these cells are T cells or natural 
killer cells. The discovery of a TCR "118 on their surface 4 years 
later finally established their T -cell lineage [3,4]. However, they are 
very unusual T cells. T cells in peripheral organs such as lymph 
nodes and spleen express a wide variety of different TCR (mostly 
TCR exl{3, with a few cells expressing TCR "1/8, both with a 
variety of different ex and (3 or "1 and 8 chains), thereby recognizing 
a wide range of different antigens. DETC, in contrast, almost 
uniformly express TCR V'Y3/V81 with identical (canonical) se­
quences [5,6]. The epidermis is the only tissue in adult mice that 
harbors TCR V'Y3 cells [5]. Their lack in the thymus of adult 
mice and the observation that adult bone-marrow-chimeric ani­
mals do not generate DETC [7] suggested that they have matura­
tional requirements different from those of other peripheral T 
cells. A very important step in understanding the ontogeny of 
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expression until or shortly after arrival in the epider­
mis. A similar loss of CDS expression by TCR Vy3+ 
cells was observed in vitro under various culture con­
ditions. To determine whether expression of CDS is 
important for the maturation of DETC. we searched 
for these cells in the epidermis of CDS-deficient 
mice. There was no alteration in the number of 
Thy-1 +/TCR Vy3+ dendritic cells in the epidermis of 
CDS -/- mice. Even though the latter finding speaks 
against a pivotal role of CDS during the maturation 
of DETC. the described cell system may serve as a 
useful tool in further experiments aimed to clarify 
the function of the CDS glycoprotein as well as the 
mechanism(s) regulating its expression. Key words: 
CD51CD21TCR "1/0.] Invest DennatoI105:54S-57S, 1995 
DETC was the finding that the thymus from fetuses at 14-1S d of 
gestation contains cells expressing exactly the same TCR V'Y3/V81 
as DETC, which suggests that these thymocytes may be DETC 
precursor cells [5]. Indeed, transplantation of fetal thymuses or 
injection of fetal thymic suspensions into congenic adult mice 
resulted in the appearance of donor-type DETC in the recipients' 
epidermis. In contrast, transplantation of thymuses from 
newborn mice, or the injection of thymocytes from adult mice 
or of fetal thymocytes depleted of TCR V'Y3 + cells, did not lead 
to the generation of DETC [S,9]. These data clearly showed 
that TCR V'Y3+ fetal thymocytes are the actual DETC precursor 
cells. Further research indicated that only stem cells from the fetal 
liver have the capacity to mature into TCR V'Y3 + cells and that the 
fetal thymic milieu is crucial for the development of these cells 
[10 , 11]. The maturation of T cells involves a whole cascade of 
different steps, as has been shown for TCR exl {3 cells (reviewed in 
[12]). It has been known since the late 19S0s that most, if not all, 
thymocytes acquire CDS and CD2 antigens early in development 
and go through a phase of CD4 and CDS coexpression before they 
mature into CD4 and CDS single-positive T cells [12-14). In 
contrast, the developmental stages that TCR "118 cells undergo 
(especially in the fetal period) were not known, and became a 
subject of research only recently [15,16]. Given that DETC are 
CDS-, CD4-, and CDS-, we studied the expression of these 
molecules on their fetal thymic precursor cells. In addition, because 
it was not known whether negativity for CDS is a stable trait of a 
given cell, or if CDS- T cells (DETC, a CDS- subpopulation 
of intraepithelial lymphocytes [17] and a few CDS - human periph­
eral blood T cells [1S]) go through a stage of CDS expression 
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Figure 1. Immunofluorescence double labeling of epidermal ear 
sheets prepared from adult B6PL mice by the NH.SCN separation 
technique. After acetone fixation, the sheets were incubated with bioti­
nylated anti-CD2 or anti-CDS MoAb, followed by Texas Red-streptavidin 
and FITC-Iabeled anti-TCR V y3 MoAb. The TCR V y3 + DETC (A,B) are 
CD2+ (b) but consistently CDS- (a). Bar, SO /Lm. 
during their development, we studied the regulation of CDS 
cell-surface expression. 
PHENOTYPIC DIFFERENCES BETWEEN TCR Vy3+ FETAL 
THYMOCYTES AND DETC 
To compare the phenotype of DETC with that of their intrathymic 
precursor cells, we first reevaluated the phenotype of DETC. 
Immunofluorescence analysis of resident DETC in epidermal sheet 
preparations as well as flow cytometric analysis of freshly prepared 
DETC-enriched epidermal single-cell suspensions did not reveal 
any detectable expression of CDS, CD4, or CD8 antigens on TCR 
Vy3+ cells (Fig 1 and data not shown). In contrast, we found that 
resident (Fig 1) as well as freshly isolated DETC [19] expressed 
CD2, a glycoprotein expressed on all T cells and thymocytes 
studied to date [14]. Three ligands for CD2 have been identified: 
CDS8 (LFA3), CDS9, and CD48 [20-22]. It remains to be seen 
whether the interaction between CD2 and its ligands expressed on 
Langerhans cells and keratinocytes [23,24], in addition to homo­
typic E-cadherin interactions (E-cadherins are expressed on Lan­
gerhans cells, keratinocytes [25], and DETC; M. Udey, personal 
communication), helps to secure the intraepithelial position of 
DETC. 
Next we investigated the expression of the above antigens on the 
intrathymic DETC precursor cells at day 17 of gestation. TCR 
V y3 + fetal thymocytes showed uniform expression of CD2 anti­
gens (Fig 2q and also reacted with anti-CDS monoclonal antibody 
(MoAb) (Fig 2A,B). Furthermore, most of these thymocytes were 
CD8+ (Fig 2E), and approximately 50% of them expressed low 
levels of CD4 antigens (Fig 2D). In summary, both our data and 
the work by Leclercq et al [15] show that both TCR V y3 + fetal 
thymocytes and DETC express CD2 antigens, but that these cells 
cillfer with respect to CDS, CD4, CD8, heat-stable antigen, and 
MEL-14 (L-selectin) expression. All of the latter antigens are 
present in the thymus but absent on DETC. 
INTENSITY OF CDS EXPRESSION DURING 
MATURATION OF TCR Vy3+ CELLS 
The transition from CD 5 + ITCR V y3 + fetal thymocytes to CD 5 - I 
TCR Vy3+ DETC was subsequently studied in more detail. 
Intravenous injection of fetal thymocyte suspensions containing 
TCR Vy3+ ICDS+ (but not TCR Vy3+ ICDS-) fetal thymocytes 
into athymic nude mice resulted in the appearance of numerous 
clusters of donor-type CD 5 - ITCR V y3 + D ETC in the recipients' 
epidermis. We observed that even the earliest donor-derived cells, 
which could be visualized in the epidermis 2 weeks after intrave-
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Figure 2. Flow cytometric analysis ofTCR Vy3+ fetal thymocytes 
at day 17 of gestation. B6PL fetal thymocytes were incubated with 
biotinylated anti-CDS (A,B), anti-CD2 (C), anti-CD4 (D), anti-CDS (E), 
or control (F) MoAb, followed by PE-SA and FITC-Iabeled anti-TCR Vy3 
MoAb: A total of 10,000 viable cells were recorded (A). Electronic gates 
were then set to acquire at least SOOO TCR V y3 + viable cells (B-F). All 
TCR Vy3+ cells expressed CDS (A,B) and CD2 (C) antigens, approxi­
mately half expressed CD4 antigens (D), and 90% expressed CDS antigens 
(E). 
nous cell transfer, were CD 5 -; this indicates that the immediate 
DETC precursor is TCR Vy3+ ICDS-. These cells could either be 
TCR Vy3+ ICDS- during their entire development (unlikely in 
view of the results presented in Fig 2) or could have lost CDS 
expression intrathymically. Because one might postulate that TCR 
Vy3+ thymocytes down-regulate CDS expression at the end of 
gestation, we studied their anti-CDS reactivity from 15 d of 
gestation until 2 d postpartum. Figure 3 shows that CDS expres­
sion was highest on TCR V y3 + cells at 15 d of gestation. Although 
at day 16 and thereafter, a fraction of TCR V y3 + cells had a 
reduced CDS cell-surface density (Fig 3), appreciable numbers of 
CDS - cells were never detected [19]. This suggests that TCR 
Vy3+ cells leave the thymus at a ·stage of intermediate CDS 
expression density. Analysis of CD 5 expression on TCR V y3 + cells 
in fetal blood, dermis, and epidermis (day 17 of gestation) showed 
that the level of CDS expression further decreased from the thymus 
to the epidermis (Table I). CDS ultimately became undetectable 
on epidermal TCR V y3 + cells at day 19 of gestation. These data, 
in conjunction with other findings-that release of DETC from 
their epidermal symbionts does not lead to CDS expression [26] and 
that culture of freshly isolated DETC in phorbol myristate acetate 
(PMA) and ionomycin (PMA up-regulates CDS expression on T 
d.y 15 cloy IS dly 17 day 18 day 19 
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Figure 3. Flow cytometric analysis of CDS and CD2 expression on 
TCR Vy3+ thymocytes obtained at 15-19 d of gestation. Fetal 
thymocyte suspensions were labeled with biotinylated anti-CDS or anti­
CD2 MoAb/PE-SA and FITC-Iabeled anti-TCR Vy3 MoAb, and only 
FITC-Iabeled cells were acquired. CDS expressi�n was down-regulated on 
TCR V y3 + cells (lane 1), whereas CD2 expression stayed constant (lane 2). 
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Table I. Intensity ofCD5 Expression on TCR Vy3+ Cells 
in Various Tissues 
Age of the MFI MFI 
Animal Tissue CDS" Control 
Day 17 fetal Thymus 15 1.6 
Day 17 fetal Blood 11 1.8 
Day 17 fetal Dennis 6.4 1.8 
Day 17 fetal Epidennis 4.9 2.1 
Day 18 fetal Epidennis 3.9 2 
Day 19 fetal Epidermis 2 2 
8-12 Weeks Epidennis 3.3 3 
a Single-cell suspensions were prepared from the indicated organs and reacted with 
biotinylated anti-CDS or control MoAb followed by fluorescein isothiocyanate 
(FITC)-conjugated anti-TCR Vy3 MoAb and phycoerythrin-streptavidin (PE-SA). 
CDS (or control) fluorescence intensity was measured with a flow cytometer on gated 
TCR Vy3 + cells using logaritlunic amplification. Data are given as the mean 
fluorescence intensity (MFI) of the respective staining. 
cells [27]) also does not lead to CDS expression (data not shown)­
indicate that the absence of CDS molecules on DETC is not due to 
suppressive signals provided by other epidermal cells. 
CDS EXPRESSION ON TCR V)'3+ THYMOCYTES 
IN VITRO 
To understand the mechanism(s) regulating CDS cell-surface den­
sity on DETC precursor cells, we studied CDS expression on 
thymocytes isolated froqJ. fetuses at day 17 of gestation and cultured 
under different conditions. Independent of whether these cells were 
maintained in plain medium, in medium supplemented with con­
canavalin A plus 10 U IL.-2, or in medium supplemented with 100 
U IL-2 (a condition leading to the preferential proliferation ofTCR 
V),3+ cells [28]), or were studied in intact thymic lobe explants, a 
complete or atleast substantial loss of CD 5 antigens on TCR V y3 + 
cells always occurred within 6-8 d [19]. Even the addition ofPMA 
and ionomycin to the cultures could not prevent the down­
regulation of CDS on these special thymocytes (Table D). This was 
surprising because PMA enhances CDS expression on lymph node 
T cells [27] as well as on TCR-al {3-expressing fetal thymocytes 
(Table D). Because we were unable to up-regulate CDS expres­
sion on TCR Vy3+ fetal thymocytes and because sorted TCR ),Ia 
fetal thymocytes lost CDS expression (ruling out down-regulatory 
signals delivered from other thymic cell populations), we conclude 
that TCR V)'3 + thymocytes may have an intrinsic program to 
down-regulate CDS and finally to lose expression of this antigen 
completely. 
MATURATION OF DETC IN CDS-DEFICIENT MICE 
The patterns of expression of CDS, CD8, and CD4 molecules 
within the thymus led to the speculation that these molecules play 
a role in the maturation andlor selection of these cells. We tested 
this hypoth�sis with respect to the CDS molecule by studying the 
Table ll. Intensity of CDS Expression After Itt Vitro 
Culture of Fetal Thyntocytes in Medium Supplemented 
With PMA apd Ionomycin 
Cell Population 
TCR V y3 + FTa 
TCR a/{3+ FT" 
TCR a/ {3+ LNb 
Day 0 
382 :!: 116 
226 :!: 25 
965 :!: 262 
Day 3 
295 :!: 123 
1065 :!: 486 
3462 :!: 327 
Day 7 
72:!: 15 
577 :!: 225 
3029 :!: 764 
d Single-cell suspensions of retal thymocytes (FT) obtained at day 17 of gestation 
were cultured for the indicated period in nonnal culture medium supplemented with 
10 "g/ml PMA and 500 nglml ionomycin. Cells were then labeled with biotinylated 
anti-CDS/PE-SA and FTTC-Iabeled anti-TCR Vy3 or anti-pan TCR al{3 MoAb. 
Samples were analyzed on a flow cytotTleter. and the mean fluorescence intensity of the 
anti-CDS staining was recorded on gated FlTC-positive cells. Mean values ± SD of 
three independent experiments are shown. 
h Single-cell suspensions were prepared from lymph nodes (LN) obtained from 
6-8-week B6PL mice. Cells were treated. stained. and analyzed as described in a. 
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FigUre •. Imrnunolluorescence detection ofTCR Vy3+ cells in the 
epidermis of a CDS-deficient C57BU6 mouse. Epidermal sheets were 
incubated with biotinylated anti-TCR Vy3 MoAb. followed by Texas 
Red-streptavidin. Note that there is no difference in the shape or the density 
of the DETC in the epidennis of the CDS-deficient mouse compared with 
normal C57BL/6 (not shown) or B6PL mice (Fig 1). Bar, 50 /Lm. 
DETC population in CDS-deficient mice [29]. Tarakhovsky et al 
[29] used the approach of homologous recombination to disrupt the 
CDS gene in a way that prevents the appearance of the CDS 
antigen on the cell surface. Mutant mice developed normally, and 
tp,e numbers and phenotypes ofT and B cells in the bone marrow, 
spleen, lymph nodes, and peritoneum of these mice matched those 
of normal control mice [29]. We prepared epidermal sheets of these 
mice and studied their reactivity with anti-Thy-l and anti-TCR 
Vy3 MoAb. As can be seen in Fig 4, there was no alteration in the 
appearance and density ofTCR V1'3+ cells in the CDS-deficient 
mice compared with normal mice (see Fig 1), and all Thy-l + cells 
coexpressed TCR Vy3. The possibility that DETC in CDS­
deficient mice have a functional defect cannot be excluded, but 
appears quite unlikely in view of studies by Tarakhovsky et al [29] 
showing no alterations in the immune function of their mice. 
Although these data argue against an important role for CDS in the 
maturation of DETC, other T cells, and B cells, it is conceivable 
that in the setting of knockout animals, other molecules may have 
substituted for the function of the CDS molecules, and alterations 
may become visible only after the inactivation of a combination of 
cell-surface markers. 
Similar to the situation in CDS-deficient mice, no alterations in 
the appearance of DETC or other TCR yla cells have been 
observed in mice in which the interactions ofCD4 or CD8 antigens 
with MHC class II or class I were interrupted as a result of 
inactivation of the latter genes [30,31]. This is not surprising 
because the intriguing TCR homogeneity of these cells is generated 
by an intrinsic program of the recombinatory machinery rather than 
from selection [32,33]. 
CONCLUDING REMARKS 
Our study of TCR V)'3 + fetal thymocytes as well as the studies 
from Leclercq et al [15] and Tatsumi et al [16] show that TCR ),Ia 
fetal thymocytes undergo several phenotypic changes during their 
maturation in the thymus. Some of these changes are similar to the 
changes of TCR al{3 thymocytes, e.g., the early expression of 
heat-stable antigen and loss of this molecule on mature cells 
[15,16]' With respect to CD4 and CD8 molecules, there are slight 
dilferences between TCR al{3 and TCR yla thymocytes . Although 
the latter possess some anti-CD4 and anti-CD8 reactivity [34,35], 
they apparendy do not go through a stage of high CD4/CD8 
double expression. Although this stage is important for the positive 
and negative selection of TCR al{3 cells, selection of TCR yla 
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cells (if it occurs at all) does not require this stage. However. the 
regulation of CDS on TCR V")'3 + fetal thymocytes contrasts 
sharply with that of TCR a/ f3 cells. Whereas the latter population 
enhances the level of CDS cell-surface density during maturation 
[19]. TCR V")'3+ thymocytes start with high CDS levels and then 
lose this antigen. The functional consequence(s) of these changes is 
unclear. especially because CDS-deficient mice generate apparently 
normal peripheral and epidermal T cells. We therefore assume that 
intrathymic expression of this glycoprotein on DETC precursor 
cells is not important for the maturation of these cells. but rather 
propose that the absence of this molecule on DETC is important for 
their fimction. CDS is associated with the TCR complex and can 
deliver stimulatory signals synergizing with TCR activation [36-
39]. In this context. it should be noted that the CDS - DETC as 
well as the TCR ")'/8, CDS_. CD2- subpopulation ofintraepithe­
lial lymphocytes exhibit a reduced proliferation in response to 
mitogens in the absence of exogenously added IL-2 [17.40.41]. 
One could therefore speculate that the absence of CDS on these 
cells increases the threshold level of antigen to which the celis 
respond. ensuring that these cells become activated OulY when the 
epidermis is damaged [42] or the bacterial load of the gut is 
enhanced [43], and not by low levels of antigen conceivably present 
in "normal" skin and gut. The cellular system described in this 
article and DETC transfected with CDS may serve as useful tools 
for experiments designed to test the proposed hypothesis and 
unravel the role of CDS. 
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